methods, and their Ca 2ϩ currents were evoked by step produce maximal desensitization, consistent with previous findings that the rate-limiting step for Ca 2ϩ channel depolarizations and measured over time. Under our recording conditions, applying 100 ms test pulses to 0 mV inhibition lies beyond the receptor and G protein (Diversé -Pierluissi and Dunlap, 1995) . produced Ca 2ϩ currents that averaged 1.2 Ϯ 0.3 nA at their peak (n ϭ 40). These currents are blocked >90% by 1 M -conotoxin GVIA, characterizing them as N-type Two Modulatory Components Desensitize (data not shown, see Cox and Dunlap, 1992) . Peak N at Different Rates current declined slowly with time, at a rate of ‫/%1ف‬min.
Our previous work has demonstrated that NE inhibits As reported by others (Jones and Marks, 1989 ; Elmslie Ca 2ϩ current by two separate biochemical pathways et al., 1993), such rundown was irreversible and, be- (Luebke and Dunlap, 1994 ; Diversé -Pierluissi et al., cause of its slow rate, could be easily separated from 1995), a G o -mediated pathway producing voltagethe more rapid onset and recovery of agonist-induced dependent slowing of the current activation kinetics inhibition ( Figure 1A ). All experimental results reported (termed kinetic slowing or KS) and a G i -mediated pathbelow have been corrected for the average rate of runway producing voltage-independent inhibition without down measured from control cells studied in parallel.
changing the activation kinetics (termed steady-state Bath application of 100 M NE inhibited N current by inhibition or SSI). These two components were sepaan average 50% Ϯ 7% (n ϭ 10) within 10 s, and upon rated and their rates of desensitization were studied termination of transmitter application, responses recovindependently using the methods outlined in Experimenered completely within 30 s ( Figure 1A , inset). With contal Procedures. Half-maximal desensitization of KS octinued superfusion of NE, the inhibition recovered slowly curred in 60 s and was complete by 100 s. By contrast, ( Figure 1B) ; this recovery process will be called desensidesensitization of SSI proceeded more slowly (half-maxtization. Its rate was estimated as the time required imal effects were observed at 100 s) and was only 80% to achieve half-maximal recovery, 100 s under control complete, even following application of 100 M transconditions (n ϭ 3). On average, peak current (corrected mitter (Figure 2 ). for rundown) returned to within 80% of control.
Effects of Purified GRKs
To evaluate whether GRKs play a role in ␣ 2 -adrenergic Concentration Dependence of the Desensitization receptor desensitization in sensory neurons, we injected individual neurons with recombinant GRKs (expressed The desensitization rate was an inverse function of transmitter concentration ( Figure 1C ), as expected for in and purified from baculovirus-infected Sf9 cells). The GRKs were added to the pipette at a concentration of homologous receptor desensitization. Application of 10 M NE inhibited peak Ca 2ϩ current by 45% Ϯ 6%, almost 10 ng/l and were pressure-injected into the cells in the presence of fluorescein-dextran. Following a 60 min as effective as 100 M NE (Canfield and Dunlap, 1984) . Desensitization of the response was greatly slowed, postinjection incubation period, cells were identified by their fluorescence, and Ca 2ϩ currents were studied under however, at the lower concentration of transmitter (Figure 1C) , with little or no desensitization detected in 10 whole-cell recording. Currents were evoked every 20 s (or every 5 s where noted) throughout the experiment, min. Lower concentrations of NE (1 M) were also tested; inhibition of 15% Ϯ 5% showed no desensitizaand responses to 100 M NE were compared with those evoked in control, uninjected cells. None of the GRKs tion over a 12 min monitoring period (data not shown). Thus, concentrations of NE that saturate the pathway tested had any effect on basal Ca 2ϩ current amplitude (1.2 Ϯ 0.3 nA in control and 1.2 Ϯ 0.4 nA in GRK-injected for onset of Ca 2ϩ current inhibition are insufficient to s in GRK3-injected cells, approximately 2-fold faster than that measured in control cells. Desensitization of SSI was half complete in 50 s (also 2-fold faster than enzymes, we performed in vitro phosphorylation assays in parallel with the electrophysiological experiments. control) and resulted in a full recovery of the control amplitude. This enhancing effect of GRK3 was specific.
Results from these assays (Figure 4) show that the preparations of GRK2 and GRK3 used in the electrophysioNo alterations in the rate of desensitization were observed in cells injected with equivalent concentrations logical experiments were equally effective in phosphorylating the ␤2-adrenergic receptor in vitro, underscoring of GRK1 (rhodopsin kinase), GRK2 (␤ARK1), or GRK5. As with GRK3, these other GRKs were without effect the selectivity of GRK3 action in the sensory neurons. on control Ca 2ϩ current amplitude or maximal inhibition produced by NE (data not shown).
Evidence for Endogenous GRKs GRK-Blocking Peptides Since GRK2 and GRK3 are 90% homologous, it was surprising that only GRK3 was effective in altering the To test whether desensitization under normal physiological conditions is mediated by a GRK3-like molecule rate of desensitization in sensory neurons. To test for possible differences in the affinities or rates of GRK in sensory neurons, we employed synthetic peptides known to interfere with GRK translocation and activation action, we increased the concentration of injected GRK2 to 250 ng/l; even this higher concentration was without . These 20 amino acid peptides have sequences identical to GRK carboxy-terminal domains effect on the rate of desensitization (data not shown). To control for possible differences in activity of the injected thought to be involved in binding G␤␥ 
Immunoassays for Endogenous GRKs
In parallel biochemical experiments, anti-GRK antisera were used to assess which types of GRK are expressed in embryonic chick sensory neurons. An immunoblot probed with antiserum raised against the carboxyl terminus of GRK3, which also recognizes GRK2, revealed a protein in sensory neurons that migrates on acrylamide gel with the same mobility as that of recombinant GRK3 ( Figure 4B ). No other GRKs were detected when similar immunoblots were probed with GRK2 and GRK5 antisera (data not shown). findings that recombinant GRK3 (but not GRK1, GRK2, or GRK5) was effective in promoting desensitization that a synthetic peptide corresponding to the G␤␥-binding and translocation to the membrane site from where the kinases phosphorylate receptors (Premont et al., 1995) .
domain of GRK3 (peptide G) blocked desensitization but the homologous peptide from GRK2 did not; and that a The peptides were introduced into sensory neurons by adding them at 100 M to the patch pipette solution GRK3-like protein was detected in immunoblot assays of protein from cultured sensory neurons. and allowing them to diffuse into the cell cytoplasm. After 10-12 min diffusion time, the cells were tested with That desensitization of NE-mediated Ca 2ϩ channel inhibition in sensory neurons involves a ␤ARK-like kinase 100 M NE and responses compared with those from control cells exposed for an equal amount of time to is consistent with reports that ␤ARK1 and ␤ARK2 (GRK2 and GRK3, respectively) are expressed widely in the normal internal solution.
Peptide G, representing residues Trp-643 to Ser-670 nervous system (Arriza et al., 1992) and that ␣ 2 -adrenergic receptors are known substrates for ␤ARK (Benovic of GRK3 (which contains the G␤␥-binding site; , greatly slowed the rate of desensitization for et al., 1987) . The inefficacy of GRK1 (rhodopsin kinase) and GRK5 in sensory neurons is further consistent with both KS and SSI, without altering peak current measured prior to NE application or its maximal inhibition by the the reduced ability of these GRKs to phosphorylate ␣ 2 -adrenergic receptors in vitro (Benovic et al., 1987 ; transmitter. During a 6 min application of transmitter, the SSI component did not reverse at all in peptide Pei et al., 1994) as well as with the reported fundamental mechanistic differences in activation of GRK1 and G-treated cells, while the KS component showed a much reduced rate of recovery, to within 65% of control GRK5, as compared with those for GRK3 (Premont et al., 1995) . Ca 2ϩ current ( Figure 5 ). This action of the GRK3 peptide G was specific: the corresponding G␤␥-binding peptide
The absence of GRK2-mediated desensitization of the NE response in sensory neurons was surprising in light from GRK2 (at 100 M) failed to alter the time course of desensitization or the magnitude of the NE-mediated of the structural and functional similarities reported for GRK2 and GRK3. Their primary structures are greater SSI when applied to sensory neurons (n ϭ 6); peptide A (100 M), representing residues Ala-531 to Trp-553 than 90% identical (Benovic et al., 1991) , their activation requires a G␤␥-mediated translocation to the membrane of GRK3 (a sequence that occurs in a region of GRK3 outside of the putative G␤␥-binding domain) was also (Pitcher et al., 1992) , and their efficacies for phosphorylating a number of receptor types in vitro are similar without effect (n ϭ 5). These findings strongly suggest that G␤␥-binding sites of GRK2 and GRK3 allow the (Inglese et al., 1993; Pei et al., 1994) . The fact that the specific G peptide from GRK3 blocks ␣ 2 -adrenergic rekinases to interact selectively with different G␤␥s.
In addition to its effect on the extent and rate of desenceptor desensitization in sensory neurons (while that from GRK2 does not) suggests a significant degree of sitization, peptide G (from GRK3) also reduced the magnitude of NE-mediated SSI. The mean inhibition was selectivity in the interactions between the GRKs and the G␤␥s that has not, as yet, been demonstrated in in vitro 45% ϩ 6% (n ϭ 10) in control cells and 25% Ϯ 5% (n ϭ 12) in peptide G-treated cells. The magnitude of biochemical assays (Pitcher et al., 1992; Koch et al., 1993; Premont et al., 1995) . It remains to be determined the kinetic slowing component was unaltered, and peptide A was without effect. The blocking action of peptide whether the ␣ 2 -adrenergic receptor-coupled signaling pathways in chick sensory neurons are unique in this G was predictable, as G␤␥ is a known intermediate in the signaling pathway producing SSI (Diversé -Pierluissi ability to discriminate between GRK2 and GRK3. Perhaps more likely, the GRKs may show reduced specificet al., 1995). Thus, peptide G simultaneously reduces NE-mediated SSI and GRK-mediated desensitization ity for certain receptors when the molecules are assayed in vitro or overexpressed in foreign environments. In through its competition for G␤␥ binding. support of this idea is a previous report that GRK3 is manner. GRK-mediated termination mechanisms at sites of synaptic contact may be particularly important more effective than GRK2 at mediating desensitization of odorant-induced signaling in excised olfactory cilia for regulating transmission via metabotropic receptors. It will be interesting to test whether GRK-induced desen- (Schleicher et al., 1993) . Future studies of GRK-receptor specificity will be greatly aided by single cell assays sitization plays a role in the rapid termination of transmitter-induced synaptic responses, longer term synaptic such as that reported here. KS and SSI desensitized at significantly different rates in our studies. The underlying depression, or both. Although these ideas have not been tested in the biochemical explanation for this is unknown, and exploring it is complicated by several properties inherent in nervous system, GRK3 has been reported to terminate rapidly odorant-induced responses in excised cilia from the signaling pathways. G i ␤␥ appears to be activating two effectors with opposing actions on Ca 2ϩ current: olfactory neurons (Schleicher et al., 1993) and is considered essential to odorant discrimination in olfactory epiphospholipase C, which produces SSI via protein kinase C-mediated phosphorylation (Diversé -Pierluissi et al., thelium (Boekhoff and Breer, 1992; Schleicher et al., 1993) . In addition, slower desensitization processes are 1995), and GRK3, which enhances the current via receptor-G protein uncoupling (as shown here). By contrast, well known to regulate cardiac sensitivity to circulating hormone levels (Homcy et al., 1991) . For example, during KS, Go␣ appears to inhibit the current (Diversé -Pierluissi et al., 1995) , while G o ␤ activates GRK. The ␤-adrenergic receptor function is impaired during heart failure (Bristow and Feldman, 1992) . Human samples selectivity of the G o ␣ for KS is suggested indirectly from experiments showing that purified G␤␥ produces N curfrom failing ventricles show a loss of ␤-adrenergic receptor-G protein coupling and increased levels of ␤ARK1 rent inhibition without altering the activation kinetics. Given that different subunits mediate the two modula- (Ungerer et al., 1994) . Furthermore, transgenic mice that overexpress ␤ARK1 demonstrate reduced cardiac contory pathways and that the subunits can interact with multiple effectors, differences in desensitization rates tractility in response to isoproterenol, while mice overexpressing a ␤ARK inhibitor showed increased contractilmight be predicted even if ␣ 2 -adrenergic receptor coupling to Gi and Go were equally effective.
ity . Voltage-activated Ca 2ϩ channels, by virtue of their To this complexity must also be added uncertainties about the number of ␣2-adrenergic receptor types indirect involvement in transmitter release, provide an effective target for use-dependent signaling pathways in volved in KS and SSI. This issue is an important one, as others report that ␣2-adrenergic receptors undergo the nervous system. The complex machinery controlling N channel inhibition in sensory neurons provides great subtype-specific, short-term desensitization (Eason and Liggett, 1992; Kurose and Lefkowitz, 1994) . Thus, the flexibility in both onset and desensitization of the agonist-induced response. Such complexity likely underlies possible involvement of multiple receptor types in sensory neurons provides a simple explanation for why KS the multifaceted responses of neural networks to changes in physiological input as well. and SSI desensitize at different rates. It is presently unknown whether each modulatory pathway in sensory neurons is activated by a separate receptor or whether Experimental Procedures a single receptor type couples to both G i and G o . IdentiCell Culture fying the rate-limiting steps in desensitization, therefore, Embryonic chicken sensory neurons were grown in culture acawaits studies using recombinant G protein subunits cording to methods described in detail elsewhere (Canfield and and blocking peptides. Dunlap, 1984) . Dorsal root ganglia were dissected from 11 to 12
Given the mechanistic differences between KS and day old embryos, incubated for 30 min in saline containing nominal SSI, it is noteworthy that desensitization of the two were Ca 2ϩ and Mg 2ϩ , and 0.05% collagenase (type A, Boehringer-Mannheim). Ganglia were dissociated mechanically into single cells by similarly enhanced by GRK3 and retarded by peptide trituration in culture medium containing Dulbecco's modified Eagle's G. Receptor phosphorylation induced by GRK3 involves medium supplemented with 10% horse serum, 5% chicken embryo a translocation of the kinase to the membrane, a process extract, penicillin, streptomycin, glutamine, and nerve growth factor. that is facilitated by its binding to the G␤␥ subunit of the Cells were plated at a density of ‫000,05ف‬ cells/collagen-coated 35 activated G protein (Pitcher et al., 1992) . The common mm tissue culture dish and studied between 1 and 3 days in vitro.
action of GRK3 against KS and SSI, therefore, implies that the G␤␥s from Gi and Go are similar. Biochemical Electrophysiological Recording assays of protein in vitro have yet to demonstrate selecStandard tight seal, whole-cell recording methods (Hamill et al., 1981) were employed. Cells were incubated in an external solution tive interactions between the GRKs and G␤␥ purified containing 133 mM NaCl, 1 mM CaCl2, O.8 mM MgCl2, 25 mM HEPES, from bovine brain (Pitcher et al., 1992; Koch et al., 1993;  12.5 mM NaOH, 5mM glucose,10 mM tetraethylammonium chloride, Premont et al., 1995; cf. Muller et al., 1993) . However, 0.3 M tetrodotoxin (pH 7.4). Experiments were performed on the as bovine brain G␤␥ is a mixture of subunit types, the stage of an inverted microscope. Recording pipettes were fabrispecificity of interaction might be more effectively evalucated from microhematocrit tubing (Fisher) and filled with an internal ated using recombinant G␤␥ dimers, for which subunit recording solution containing 150 mM CsCl, 5 BAPTA, 5 MgATP, 10 HEPES (pH 7.2). All salts were obtained from Fluka. Initial pipette composition is known. coupling require agonist binding, they are ideally suited
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